TMEM70 Antibodies

Santa Cruz Biotechnology features a diverse variety of TMEM70 monoclonal antibodies for research focused on understanding mitochondrial function and energy metabolism. Multiple validated applications include western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TMEM70 plays a crucial role in mitochondrial function, particularly in the assembly of ATP synthase, which is essential for ATP production. Proper TMEM70 function maintains cellular energy metabolism, while mutations in TMEM70 have been linked to various mitochondrial disorders. Research into TMEM70 continues to reveal important insights about metabolic diseases and potential therapeutic approaches. Investigating TMEM70 expression and localization helps advance understanding of mitochondrial biology and disease mechanisms. Current studies focus on how TMEM70 regulates ATP synthase assembly and its impact on cellular energy production. Ongoing research examines TMEM70's role in different tissue types and developmental stages. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific knowledge of mitochondrial function and metabolic disease mechanisms.